Pharmaceutical Industry Information Portal

HomeNews

News

R-Pharm announces the signing of a distribution agreement with PHC Europe B.V.

Etten-Leur, Tokyo, Moscow, June 9, 2021. R-Pharm Group announces the signing of a distribution agreement with PHC Europe B.V., one of the largest suppliers...

FDA Approves Pfizer’s Pneumococcal 20-valent Conjugate Vaccine For Adults

The U.S. Food and Drug Administration has approved Pfizer Inc.'s (PFE) PREVNAR 20 or Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae or pneumococcus serotypes in the vaccine in adults ages 18 years and older.

Ministry of Health of the Russian Federation issues permit for post-registration trials of CoviVac

The Russian Health Ministry has issued a permit to conduct the post-registration clinical trials of the CoviVac shot against the coronavirus infection with the...

R-Pharm and Beijing Health Guard entered into collaboration agreements of a HPV vaccine

The agreements provide for the conduct of phase III clinical trials and registration of the nonavalent HPV vaccine in Russia.

Brazil becomes the 67th country in the world to authorize Sputnik V vaccine

The vaccine was authorized for import and use by Brazilian states after ANVISA considered the technical report provided by Russia’s Health Ministry.

East-Pharm to Choose Kaluga SEZ

East-Pharm is a modern Russian high-tech pharmaceutical company specializing in the production of infusion solutions in accordance with GMP.
spot_img

Expert Articles

spot_img